Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
pharmaceutical company signed a license agreement with a biotech for the co-development of a novel GLP-1/glucagon dual-agonist (to complement its existing portfolio)
Therefore, new therapeutic strategies should be developed based on the researched mechanism to protect GC while effectively killing ectopic endometrial cells, thereby alleviating the suffering of patients
HCG radioantibodies in the radioimmunodetection of oncology research models and for [PMID: 6278487] Laboratory literature summary: hCG radioantibodies in the radioimmunodetection of oncology research models and for disclosure of occult metastases
BPC-157 concentrates at injection sites with targeted tendon and ligament repair plus strong gastrointestinal healing
US$ 24.95
US$ 29.73
US$ 27.53
US$ 22.40
US$ 28.42
US$ 25.51
US$ 26.07
US$ 24.93
US$ 24.16
